Literature DB >> 26780940

MicroRNA-27b suppresses Helicobacter pylori-induced gastric tumorigenesis through negatively regulating Frizzled7.

Yan Geng1, Xiaolan Lu2, Xiaokang Wu1, Li Xue1, Xiangling Wang1, Jiru Xu3.   

Abstract

MicroRNAs (miRNAs) are novel tools for cancer therapy. Frizzled7 (FZD7) is an important co-receptor in the WNT signaling pathway. The WNT signaling pathway is aberrantly activated in Helicobacter pylori (H. pylori)‑infected gastric cancer cells. However, the role of FZD7 in H. pylori‑induced gastric tumorigenesis remains unknown. In this study, we investigated the potential role of FZD7 in H. pylori-induced gastric tumorigenesis and validated the possibility that targeting of FZD7 by specific miRNA inhibits H. pylori-induced gastric tumorigenesis. First, we found that FZD7 was significantly induced by H. pylori infection in a dose- and time-dependent manner. Knockdown of FZD7 by FZD7 small interfering RNA effectively inhibited H. pylori infection-induced cell proliferation of gastric cancer cells. We found that microRNA-27b (miR-27b) was the predicted miRNA for FZD7 and that miR-27b negatively regulated FZD7 expression by targeting the 3'-untranslated region of FZD7. Furthermore, miR-27b overexpression significantly inhibited H. pylori infection-induced cell proliferation and WNT signaling pathway activation in gastric cancer cells. Restoration of FZD7 expression significantly attenuated the inhibitory effect of miR-27b overexpression on cell proliferation and WNT signaling pathway activation. Collectively, our study suggests that FZD7 triggered by H. pylori infection contributes to the H. pylori infection-induced cell proliferation that links the WNT. Thus, miR-27b may be a promising molecular target for the treatment of the disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26780940     DOI: 10.3892/or.2016.4572

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  23 in total

Review 1.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

2.  HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma.

Authors:  Y J Jia; Z B Liu; W G Wang; C B Sun; P Wei; Y L Yang; M J You; B H Yu; X Q Li; X Y Zhou
Journal:  Leukemia       Date:  2017-09-28       Impact factor: 11.528

Review 3.  MicroRNA in gastrointestinal cell signalling.

Authors:  Priyanka Mishra; Divya Singh; Lilly Ganju; Bhuvnesh Kumar
Journal:  Inflammopharmacology       Date:  2017-11-06       Impact factor: 4.473

4.  MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.

Authors:  Xin-Fang Sun; Jin-Ping Sun; Hong-Tao Hou; Ke Li; Xin Liu; Quan-Xing Ge
Journal:  Tumour Biol       Date:  2016-10-04

5.  Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes.

Authors:  Cheng Chen; Lunan Luo; Changling Xu; Xia Yang; Ting Liu; Jingyue Luo; Wen Shi; Lu Yang; Yi Zheng; Jing Yang
Journal:  BMC Cancer       Date:  2022-07-19       Impact factor: 4.638

Review 6.  Noncoding RNAs in gastric cancer: Research progress and prospects.

Authors:  Meng Zhang; Xiang Du
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

Review 7.  WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.

Authors:  Else Driehuis; Hans Clevers
Journal:  Br J Pharmacol       Date:  2017-04-04       Impact factor: 8.739

Review 8.  Clinical crosstalk between microRNAs and gastric cancer (Review).

Authors:  Jing Ouyang; Zhizhong Xie; Xiaoyong Lei; Guotao Tang; Runliang Gan; Xiaoyan Yang
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

9.  Combined targeting of vascular endothelial growth factor C (VEGFC) and P65 using miR-27b-3p agomir and lipoteichoic acid in the treatment of gastric cancer.

Authors:  Yejia Cui; Shaolong Huang; Jin Cao; Jinjun Ye; Haohai Huang; Dan Liao; Yufeng Yang; Wanchan Chen; Rong Pu
Journal:  J Gastrointest Oncol       Date:  2021-02

Review 10.  Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat Cancer.

Authors:  Toby Phesse; Dustin Flanagan; Elizabeth Vincan
Journal:  Cancers (Basel)       Date:  2016-05-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.